Picture Berlin Partner Top News Cambrium Biobased AI Materials 650x100px

Product › Details

CAR T-cell technology (Chimeric Antigen Receptor T-Cell technology)

	Next higher product group	Chimeric Antigen Receptor technology (CAR technology)
	Status	2012-10-06
	Organisation	Novartis (Group)
	Original research	University of Pennsylvania (UPenn)

Record changed: 2024-11-26

Picture Swiss Biotech Association Swiss Biotech Days 2025 SBD25 Basel 650x200px

More documents for CAR T-cell technology (Chimeric Antigen Receptor T-Cell technology)

[1] Roche. (11/26/24). "Press Release: Roche Enters into a Definitive Agreement to Acquire Poseida Therapeutics, Including Cell Therapy Candidates and Related Platform technologies". Basel....
[2] T-Curx GmbH. (2/9/24). "Press Release: T-Curx Extends Its Management Team with Marion Jung, PhD, as Its New Chief Operating Officer"....
[3] Legend Biotech Corporation. (11/13/23). "Press Release: Legend Biotech Announces Exclusive, Global License Agreement for Certain CAR-T Therapies Targeting DLL3". Somerset, NJ....
[4] T-Curx GmbH. (10/6/22). "Press Release: T-Curx GmbH, a German CAR-T Cell Biotech Spin-Off from University of Würzburg, Appoints Ulf Grawunder as CEO". Würzburg....
[5] Arsenal Biosciences, Inc.. (9/27/22). "Press Release: Arsenal Biosciences Announces Joint Discovery Collaboration with Genentech to Identify Features of Successful T-Cell Therapies for Oncology". South San Francisco, CA....
[6] Poseida Therapeutics, Inc.. (8/3/22). "Press Release: Poseida Therapeutics Announces Strategic Global Collaboration with Roche Focused on Allogeneic CAR-T Cell Therapies for Hematologic Malignancies". San Diego, CA....
[7] Atara Biotherapeutics, Inc.. (5/19/22). "Press Release: Atara Biotherapeutics Provides Update on Strategic Collaboration with Bayer". South San Francisco, CA....
[8] Sirion Biotech GmbH. (1/7/21). "Press Release: Sirion Biotech GmbH Licensed Its LentiBoost Transduction Technology to Cellectis". Munich & Cambridge, MA....
[9] Bayer AG. (12/6/20). "Press Release: Bayer and Atara Biotherapeutics Enter Strategic Collaboration for Mesothelin-Targeted CAR T-cell Therapies for Solid Tumors". Whippany, NJ & South San Francisco, CA....
[10] Gemoab GmbH. (7/20/20). "Press Release: Gemoab and Intellia Therapeutics Enter into Research Collaboration and Licensing Agreement on Next-Generation Cellular Immunotherapy". Dresden....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)